4DX — 4DMedical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$238.44m
- AU$195.11m
- AU$0.72m
- 12
- 12
- 57
- 16
Annual cashflow statement for 4DMedical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -1.18 | -2.85 | -2.19 | -4.4 | -4.18 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.78 | -7.65 | -14.5 | -25.3 | -22.7 |
| Capital Expenditures | -1.28 | -1.16 | -0.952 | -3.5 | -1.61 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.253 | 0.372 | 0.372 | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.03 | -0.786 | -0.58 | -3.5 | -1.61 |
| Financing Cash Flow Items | — | -1.5 | -6.38 | 0 | -1.19 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.23 | 13.8 | 87.6 | -0.995 | 42.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.42 | 5.34 | 72.5 | -29.8 | 18.5 |